Therapeutic strategies for postremission treatment in childhood acute myeloid leukemia (AML). The AIEOP experience 1987-1991.

Amadori, S; Giona, F; Giuliano, M; Moleti, M L; Pession, A; Rolla, M; Rondelli, R; Testi, A M; Mandelli, F

Amadori, S; Giona, F; Giuliano, M; Moleti, M L; Pession, A; Rolla, M; Rondelli, R; Testi, A M; Mandelli, F.

Affiliation

Amadori S; Institute of Hematology, University La Sapienza, Rome.

Leukemia ; 6 Suppl 2: 44-7, 1992.

Article in En | MEDLINE | ID: mdl-1578940

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Leukemia, Myeloid/drug therapy; Acute Disease; Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Cytarabine/administration & dosage; Daunorubicin/administration & dosage; Female; Humans; Infant; Italy; Leukemia, Myeloid/mortality; Leukemia, Myeloid/surgery; Male; Pilot Projects; Random Allocation; Recurrence; Remission Induction

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Leukemia, Myeloid Type of study: Clinical_trials / Guideline Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Country/Region as subject: Europa Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 1992 Type: Article

Search on Google

XML

PubMed Links